As a growing number of overweight Americans clamor for Ozempic and Wegovy -- drugs touted by celebrities and on TikTok to pare pounds -- an even more powerful obesity medicine is poised to upend treatment.
Tirzepatide, an Eli Lilly and Co. drug approved to treat Type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity lose up to 16% of their body weight, or more than 34 pounds, over nearly 17 months, the company said on Thursday.
If approved for weight loss, tirzepatide could become the most effective drug to date in an arsenal of medications that are transforming the treatment of obesity, which affects more than 4 in 10 American adults and is linked to dozens of diseases that can lead to disability or death. Mounjaro was first approved to treat diabetes last year. Since then, thousands of patients have obtained the drug from doctors and telehealth providers who prescribed it"off-label" to help them slim down.
"They have entirely changed the landscape," said Dr. Amy Rothberg, a University of Michigan endocrinologist who directs a virtual weight loss and diabetes program. Ozempic and Wegovy are two versions of semaglutide. That drug mimics a key gut hormone, known as GLP-1, that is activated after people eat, boosting the release of insulin and slowing release of sugar from the liver. It delays digestion and reduces appetite, making people feel full longer.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Powerful new obesity drug from Eli Lilly and Co. poised to upend weight loss careAs a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
Read more »
Powerful new obesity drug poised to upend weight loss careAs a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment
Read more »
Powerful new obesity drug poised to upend weight loss careAs a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
Read more »
6 Ozempic facts that make sense of social media hypeSix weight loss drugs facts that you need to know, including how Ozempic works and common Ozempic side effects.
Read more »
Another Weight Loss Drug Could Soon Join Ozempic in U.S.A diabetes drug could soon gain FDA approval for weight loss after manufacturer Eli Lilly said Thursday it showed patients lost significant amounts of weight after 72 weeks of treatment.
Read more »
Rival Ozempic Drug Helped Diabetes Patients Shed Up to 34 Pounds: TrialPharmaceutical giant Eli Lilly on Thursday made an announcement—not that insulin is free now, but that a different drug it makes helped obese, diabetic patients shed almost 16 percent of their body weight over nearly 17 months.
Read more »